Hypothesis

14 Matching Annotations

Last 7 days
aacrjournals.org aacrjournals.org

KLF5 Activation Promotes Malignant Transformation to Drive Development of Lung Squamous Cell Carcinoma

1
1. scibot 12 Jul 2026
  
  in Public
  
  CVCL_5137
  
  DOI: 10.1158/0008-5472.CAN-25-2139
  
  Resource: (KCLB Cat# 70095, RRID:CVCL_5137)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_5137
  
  What is this?
  
  RRID:CVCL_5137
Visit annotations in context

Tags

RRID:CVCL_5137

Annotators

scibot

URL

aacrjournals.org/cancerres/article/86/7/1622/775642/KLF5-Activation-Promotes-Malignant-Transformation
Feb 2024
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas

1
1. scibot 15 Feb 2024
  
  in Public
  
  RRID:CVCL_5137
  
  DOI: 10.1158/2767-9764.CRC-23-0399
  
  Resource: (KCLB Cat# 70095, RRID:CVCL_5137)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_5137
  
  What is this?
  
  RRID:CVCL_5137
Visit annotations in context

Tags

RRID:CVCL_5137

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC10863487/
Jan 2024
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma

1
1. scibot 26 Jan 2024
  
  in Public
  
  CVCL_5137
  
  DOI: 10.1101/2023.05.04.539399
  
  Resource: (KCLB Cat# 70095, RRID:CVCL_5137)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_5137
  
  What is this?
  
  RRID:CVCL_5137
Visit annotations in context

Tags

RRID:CVCL_5137

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC10187264/
www.sciencedirect.com www.sciencedirect.com

Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma

1
1. scibot 11 Jan 2024
  
  in Public
  
  RRID: CVCL_5137
  
  DOI: 10.1016/j.molcel.2023.12.003
  
  Resource: (KCLB Cat# 70095, RRID:CVCL_5137)
  
  Curator: @abever99
  
  SciCrunch record: RRID:CVCL_5137
  
  What is this?
  
  RRID:CVCL_5137
Visit annotations in context

Tags

RRID:CVCL_5137

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1097276523010225
Jan 2023
www.sciencedirect.com www.sciencedirect.com

KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition

1
1. scibot 28 Jan 2023
  
  in Public
  
  RRID: CVCL_5137
  
  DOI: 10.1016/j.ccell.2022.11.015
  
  Resource: (KCLB Cat# 70095, RRID:CVCL_5137)
  
  Curator: @sofiakhan13
  
  SciCrunch record: RRID:CVCL_5137
  
  What is this?
  
  RRID:CVCL_5137
Visit annotations in context

Tags

RRID:CVCL_5137

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610822005621
Oct 2022
www.nature.com www.nature.com

Self-restricted circular RNA circSOX2 suppressed the malignant progression in SOX2-amplified LUSC

1
1. scibot 18 Oct 2022
  
  in Public
  
  RRID: CVCL 5137
  
  DOI: 10.1038/s41419-022-05288-5
  
  Resource: (KCLB Cat# 70095, RRID:CVCL_5137)
  
  Curator: @a5munoz
  
  SciCrunch record: RRID:CVCL_5137
  
  What is this?
  
  RRID:CVCL_5137
Visit annotations in context

Tags

RRID:CVCL_5137

Annotators

scibot

URL

nature.com/articles/s41419-022-05288-5
Jun 2022
aacrjournals.org aacrjournals.org

Zenocutuzumab, a HER2xHER3 bispecific antibody, is effective therapy for tumors driven by NRG1 gene rearrangements

1
1. scibot 01 Jun 2022
  
  in Public
  
  RRID:CVCL_5137
  
  DOI: 10.1158/2159-8290.CD-21-1119
  
  Resource: (KCLB Cat# 70095, RRID:CVCL_5137)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_5137
  
  What is this?
  
  RRID:CVCL_5137
Visit annotations in context

Tags

RRID:CVCL_5137

Annotators

scibot

URL

aacrjournals.org/cancerdiscovery/article/12/5/1233/694554/Zenocutuzumab-a-HER2xHER3-Bispecific-Antibody-Is
Dec 2021
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

The anti-HER3 monoclonal antibody seribantumab effectively inhibits growth of patient-derived and isogenic cell line and xenograft models with oncogenic NRG1 fusions

1
1. scibot 02 Dec 2021
  
  in Public
  
  RRID:CVCL_5137
  
  DOI: 10.1158/1078-0432.CCR-20-3605
  
  Resource: (KCLB Cat# 70095, RRID:CVCL_5137)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_5137
  
  What is this?
  
  RRID:CVCL_5137
Visit annotations in context

Tags

RRID:CVCL_5137

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC8172458/
Aug 2021
www.sciencedirect.com www.sciencedirect.com

Transmembrane Protease TMPRSS11B Promotes Lung Cancer Growth by Enhancing Lactate Export and Glycolytic Metabolism

1
1. scibot 04 Aug 2021
  
  in Public
  
  RRID:CVCL_5137
  
  DOI: 10.1016/j.celrep.2018.10.100
  
  Resource: (KCLB Cat# 70095, RRID:CVCL_5137)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_5137
  
  What is this?
  
  RRID:CVCL_5137
Visit annotations in context

Tags

RRID:CVCL_5137

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2211124718317224
www.sciencedirect.com www.sciencedirect.com

RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer

1
1. scibot 01 Aug 2021
  
  in Public
  
  RRID:CVCL_5137
  
  DOI: 10.1016/j.chembiol.2019.12.005
  
  Resource: (KCLB Cat# 70095, RRID:CVCL_5137)
  
  Curator: @ethanbadger
  
  SciCrunch record: RRID:CVCL_5137
  
  What is this?
  
  RRIDCUR:Validated RRID:CVCL_5137
Visit annotations in context

Tags

RRID:CVCL_5137

RRIDCUR:Validated

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2451945619304015
Jul 2021
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Untitled document

1
1. scibot 30 Jul 2021
  
  in Public
  
  RRID:CVCL_5137
  
  DOI: 10.7554/eLife.33718
  
  Resource: (KCLB Cat# 70095, RRID:CVCL_5137)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_5137
  
  What is this?
  
  RRID:CVCL_5137 RRIDCUR:Validated
Visit annotations in context

Tags

RRID:CVCL_5137

RRIDCUR:Validated

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC6298772/
www.sciencedirect.com www.sciencedirect.com

PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity

1
1. scibot 23 Jul 2021
  
  in Public
  
  70095
  
  DOI: 10.1016/j.ccell.2021.06.018
  
  Resource: (KCLB Cat# 70095, RRID:CVCL_5137)
  
  Curator: @Naa003
  
  SciCrunch record: RRID:CVCL_5137
  
  What is this?
  
  RRID:CVCL_5137 RRIDCUR:Missing
Visit annotations in context

Tags

RRIDCUR:Missing

RRID:CVCL_5137

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610821003408
Jun 2021
cancerdiscovery.aacrjournals.org cancerdiscovery.aacrjournals.org

TNIK is a therapeutic target in Lung Squamous Cell Carcinoma and regulates FAK activation through Merlin.

1
1. scibot 29 Jun 2021
  
  in Public
  
  RRID:CVCL_5137
  
  DOI: 10.1158/2159-8290.CD-20-0797
  
  Resource: (KCLB Cat# 70095, RRID:CVCL_5137)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_5137
  
  What is this?
  
  RRID:CVCL_5137
Visit annotations in context

Tags

RRID:CVCL_5137

Annotators

scibot

URL

cancerdiscovery.aacrjournals.org/content/11/6/1411
Jan 2020
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Untitled document

1
1. scibot 12 Jan 2020
  
  in Public
  
  RRID:CVCL_5137
  
  DOI: 10.7554/eLife.33718
  
  Resource: (KCLB Cat# 70095, RRID:CVCL_5137)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_5137
  
  What is this?
  
  RRID:CVCL_5137 RRIDCUR:Validated
Visit annotations in context

Tags

RRID:CVCL_5137

RRIDCUR:Validated

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC6298772/